Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trabecular Bone Score (TBS) as an Innovative Parameter Evaluation for Bone Disease's in Multiple Sclerosis (MS) Patients and Impact of Osteoporosis on the Quality of Life of Patients With MS

NCT05811689 is registered in ClinicalTrials.gov with IRCCS Centro Neurolesi Bonino Pulejo as lead sponsor.

NCT NCT05811689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05811689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trabecular Bone Score (TBS) as an Innovative Parameter Evaluation for Bone Disease's in Multiple Sclerosis (MS) Patients and Impact of Osteoporosis on the Quality of Life of Patients With MS
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Phase
Observational
Overall status
Completed
Start date
February 14, 2021
Completion date
February 15, 2023
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocrine system diseases, multiple sclerosis, neurologic disorder